Turnaround

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...

The biotech firm Ocugen has staged a remarkable recovery in recent months, capturing renewed attention from institutional investors. This resurgence...

Investors have returned to Battalion Oil with conviction, propelling the company's stock to a gain of approximately 16% on Wednesday....

Biopharmaceutical firm CytomX Therapeutics has positioned itself for a significant clinical push following a substantial equity raise. The company confirmed...

For shareholders of Gene Biotherapeutics, the wait for substantive news continues. The company, formerly known as Taxus Cardium Pharmaceuticals Group,...

In a decisive move to secure its financial future, New Fortress Energy has announced a sweeping restructuring agreement with its...

Facing persistent softness in the U.S. housing sector, American Woodmark has initiated a comprehensive strategic overhaul. The cabinet and fixture...

Neonode is undergoing a fundamental strategic reinvention. The company's management is steering a radical transformation toward becoming a specialized software...

Mount Logan Capital is implementing a significant internal reorganization during the first quarter of 2026. The alternative asset manager is...

Versamet (VERSAMET) has concluded its 2025 fiscal year by delivering record-breaking financial results, marking a significant operational turning point for...